| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |